Skip to main content
Log in

Does Mechanical Thrombectomy in Acute Embolic Stroke Have Long-term Side Effects on Intracranial Vessels? An Angiographic Follow-up Study

  • Clinical Investigation
  • Published:
CardioVascular and Interventional Radiology Aims and scope Submit manuscript

Abstract

Purpose

Mechanical thrombectomy (mTE) proved to be effective treating acute vessel occlusions with an acceptable rate of procedural complications. Potential long-term side effects of the vessel wall trauma caused by mechanical irritation of the endothelium are unknown up to now.

Methods

From a retrospectively established database of 640 acute stroke treatments, we selected 261 patients with 265 embolic vessel occlusions treated successfully by mTE without permanent implantation of a stent. Analysis comprised the type of devices used and the number of passes performed. Digital subtraction angiography immediately after treatment was evaluated for vasospasm, dissection, and extravasation. Control angiographic images were evaluated for any morphological change compared to the immediate posttreatment angiographic run.

Results

Recanalization was achieved with a median of one (range 1–10) mTE maneuvers. Vasospasm occurred in 69 territories (26.0 %) and was treated with glyceroltrinitrate in three. Dissection was observed in one vessel (0.4 %). Intraprocedural hemorrhage in two patients (0.8 %) was either wire or device induced. Follow-up digital subtraction angiography was available for 117 territories after a median of 107 days, revealing target vessel occlusion in one segment (0.9 %) and a de novo stenosis of four segments (3.4 %). All findings were clinically asymptomatic. Posttreatment vasospasm was more frequent in patients with de novo stenosis and occlusion (p = 0.038).

Conclusion

De novo stenoses and occlusions occur in a small proportion of patients after mTE. Because all lesions were clinically asymptomatic, this finding does not affect the overall benefit of the treatment. Vasospasm may predict late vessel wall changes.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  1. National Institute of Neurological Disorders and Stroke RT-PA Stroke Study Group (1995) Tissue plasminogen activator for acute ischemic stroke. N Engl J Med 333:1581–1587

    Article  Google Scholar 

  2. Hakke W, Kaste M, Bluhmki E et al (2008) Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke. N Engl J Med 359:1317–1329

    Article  Google Scholar 

  3. Lansberg MG, Schrooten M, Bluhmki E et al (2009) Treatment time specific number needed to treat estimates for tissue plasminogen activator therapy in acute stroke based on shifts over the entire range of the modified Rankin scale. Stroke 40:2079–2084

    Article  PubMed  CAS  Google Scholar 

  4. Saver JL, Gornbein J, Grotta J et al (2009) Number needed to treat to benefit and harm for intravenous tissue plasminogen activator therapy in the 3- to 4.5-hour window: joint outcome table analysis of the ECASS 3 trial. Stroke 40:2433–2437

    Article  PubMed  CAS  Google Scholar 

  5. Riedel CH, Zimmermann P, Jensen-Kondering U et al (2011) The importance of size: successful recanalization by intravenous thrombolysis in acute anterior stroke depends on thrombus length. Stroke 42:1775–1777

    Article  PubMed  Google Scholar 

  6. Saqqur M, Uchino K, Demchuk AM et al (2007) Site of arterial occlusion identified by transcranial Doppler predicts the response to intravenous thrombolysis for stroke. Stroke 38:948–954

    Article  PubMed  Google Scholar 

  7. Mattle HP, Arnold M, Georgiadis D et al (2008) Comparison of intraarterial and intravenous thrombolysis for ischemic stroke with hyperdense middle cerebal artery sign. Stroke 39:379–383

    Article  PubMed  Google Scholar 

  8. Smith WS, Sung G, Saver J et al (2008) Mechanical thrombectomy for acute ischemic stroke: final results of the Multi MERCI trial. Stroke 39:1205–1212

    Article  PubMed  Google Scholar 

  9. Mourand I, Brunel H, Costalat V et al (2011) Mechanical thrombectomy in acute ischemic stroke: catch device. AJNR Am J Neuroradiol 32:1381–1385

    Article  PubMed  CAS  Google Scholar 

  10. Henkes H, Reinartz J, Lowens S et al (2006) A device for fast mechanical clot retrieval from intracranial arteries (Phenox clot retriever). Neurocrit Care 5:134–140

    Article  PubMed  Google Scholar 

  11. Penumbra Pivotal Stroke Trial Investigators (2009) The penumbra pivotal stroke trial: safety and effectiveness of mechanical devices for clot removal in intracranial large vessel occlusive disease. Stroke 40:2761–2768

    Article  Google Scholar 

  12. Pérez MA, Miloslavski E, Fischer S et al (2012) Intracranial thrombectomy using the Solitaire stent: a historical vignette. J Neurointerv Surg 4:154

    Article  Google Scholar 

  13. Castaño C, Dorado L, Guerrero C et al (2010) Mechanical thrombectomy with the Solitaire AB device in large artery occlusion of the anterior circulation: a pilot study. Stroke 41:1836–1840

    Article  PubMed  Google Scholar 

  14. Machi P, Costalat V, Lobotesis K et al (2012) Solitaire FR thrombectomy system: immediate results in 56 consecutive acute ischemic stroke patients. J Neurointerv Surg 4:62–66

    Article  PubMed  Google Scholar 

  15. Rohde S, Haehnel S, Herweh C et al (2011) Mechanical thrombectomy in acute embolic stroke: preliminary results with the revive device. Stroke 42:2954–2956

    Article  PubMed  Google Scholar 

  16. Nedeltchev K, Schwengler B, Haefeli T et al (2007) Outcome of stroke with mild or rapidly improving symptoms. Stroke 38:2531–2535

    Article  PubMed  Google Scholar 

  17. Rajajee V, Kidwell C, Starkman S et al (2006) Early MRI and outcomes of untreated patients with mild or improving ischemic stroke. Neurology 67:980–984

    Article  PubMed  CAS  Google Scholar 

  18. Möhlenbruch M, Seifert M, Okulla T et al (2011) Mechanical thrombectomy compared to local-intraarterial thrombolysis in carotid T and middle cerebral artery occlusions: a single center experience. Clin Neuroradiol. doi:10.1007/s00062-011-0099-9

    PubMed  Google Scholar 

  19. Jahan R (2010) Solitaire flow-restoration device for treatment of acute ischemic stroke: safety and recanalization efficacy study in a swine vessel occlusion model. AJNR Am J Neuroradiol 31:1938–1943

    Article  PubMed  CAS  Google Scholar 

  20. Mordasini P, Frabetti N, Gralla J et al (2011) In vivo evaluation of the first dedicated combined flow-restoration and mechanical thrombectomy device in a swine model of acute vessel occlusion. AJNR Am J Neuroradiol 32:294–300

    Article  PubMed  CAS  Google Scholar 

  21. Nogueira RG, Levy EI, Gounis M et al (2012) The Trevo device: preclinical data of a novel stroke thrombectomy device in two different animal models of arterial thrombo-occlusive disease. J Neurointerv Surg 4:295–300

    Article  PubMed  Google Scholar 

  22. Gupta R (2009) Arterial vasospasm during mechanical thrombectomy for acute stroke. J Neuroimaging 19:61–64

    Article  PubMed  Google Scholar 

  23. Smith WS, Sung G, Starkman S et al (2005) Safety and efficacy of mechanical embolectomy in acute ischemic stroke. Results of the MERCI trial. Stroke 36:1432–1440

    Article  PubMed  Google Scholar 

  24. Yin NS, Benavides S, Starkman S et al (2010) Autopsy findings after intracranial thrombectomy for acute ischemic stroke—a clinicopathologic study of 5 patients. Stroke 41:938–947

    Article  PubMed  Google Scholar 

Download references

Conflict of interest

W. Kurre is a consultant to Phenox, received travel expenses from Phenox, and received speaker honoraria from Codman and Shurtleff Inc. M. Aguilar-Pérez is a consultant to Phenox. D. Horvath does not have any conflict of interest. E. Schmid received speaker honoraria from Bayer vital. H. Bäzner received speaker honoraria from Bayer vital, UCB Pharma, Biogen Idec and Boehringer Ingelheim. H. Henkes received speaker honoraria as well as travel expenses from Covidien/ev3 and Codman and Shurtleff Inc. He was cofounder of Dendron (the company that developed the Solitaire and was later acquired by ev3) and Phenox (the company that developed the pREset retriever).

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Hans Henkes.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kurre, W., Pérez, M.A., Horvath, D. et al. Does Mechanical Thrombectomy in Acute Embolic Stroke Have Long-term Side Effects on Intracranial Vessels? An Angiographic Follow-up Study. Cardiovasc Intervent Radiol 36, 629–636 (2013). https://doi.org/10.1007/s00270-012-0496-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00270-012-0496-8

Keywords

Navigation